How much revenue does Kwality Pharmaceuticals make?

Kwality Pharmaceuticals reported 3.70 billion INR in revenue for fiscal year 2025, up 20.5% from 3.07 billion INR in fiscal year 2024. In Q3 2026 revenue was 1.23 billion INR.

What companies are similar to Kwality Pharmaceuticals?

Listed companies of a similar size in the same industry (drug manufacturing contractors) include Gujarat Themis Biosyn Limited (GUJTHEM.BO), SMS Pharmaceuticals Limited (SMSPHARMA.NS), Aarti Drugs Limited (AARTIDRUGS.NS), Solara Active Pharma Sciences Limited (SOLARA.NS).

Kwality Pharmaceuticals Limited (KPL.BO) Stock

About Kwality Pharmaceuticals Limited

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including capsules, eye and ear drops, ointments and creams, pouches and sachets, sanitizers, tablets, suppositories, injectable vials and ampoules, liquid orals, lyophilized products, syrups, and var...

At a glance

Kwality Pharmaceuticals reported revenue of 3.70 billion INR for fiscal year 2025, up 20.5% from fiscal year 2024, and net income of 398.45 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 1.23 billion INR, up 46.2% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.